Synthesis of Tricyclic b-Lactams
FULL PAPER
9.0 Hz, each 2H; ArH), 4.85 (t, J=2.2 Hz, 2H; =CH2), 4.57 (dd, J=5.8,
4.6 Hz, 1H; H2), 4.07 (brs, 1H; H3), 3.78 (s, 3H; OMe), 3.38 (d, J=
4.6 Hz, 1H; H8), 3.19 (dt, J=16.0, 1.9 Hz, 1H; H6), 2.51 (dt, J=16.0,
2.9 Hz, 1H; H6’), 1.75 (brs, 1H; OH), 1.26 (s, 3H; Me), 1.15 ppm (s, 3H;
Me); 13C NMR (75 MHz, CDCl3, 258C): d=165.8 (C9), 156.1, 151.2 (C=
CH2), 131.6, 118.6 (Ar), 114.2 (Ar), 106.9 (C=CH2), 82.5 (C2), 62.8, 61.2,
61.1, 55.4(OMe), 14.3, 37.8 (C6), 21.9 (Me), 20.5 ppm (Me); IR
(CHCl3): n˜ =3310, 1734cm À1; MS (EI): m/z (%): 300 (20) [M+H]+, 299
(100) [M]+; elemental analysis (%) calcd for C18H21NO3 (299.4): C 72.22,
H 7.07, N 4.68; found C 72.09, H 7.03, N 4.70.
Pecunioso, F. Busi, S. A. Contini, D. Donati, M. Maffeis, D. A. Pizzi,
L. Rossi, T. Rossi, F. M. Sabbatine, Tetrahedron 2000, 56, 5649; d) C.
Ghiron, T. Rossi, The Chemistry of Trinems in Targets in Heterocy-
clic Systems-Chemistry and Properties, Vol. 1 (Eds.: O. A. Attanasi,
D. Spinelli), Societa Chimica Italiana, Rome, 1997, pp. 161–186;
e) J. Ngo, J. CastaÇer, Drugs Future 1996, 21, 1238.
[4] For a review on bi- and tricyclic-b-lactams with a nonclassical struc-
ture see: B. Alcaide, P. Almendros, Curr. Org. Chem. 2002, 6, 245.
[5] Some of the more notable advances concern the development of
mechanism-based serine protease inhibitors of elastase, cytomegalo-
virus protease, thrombin, prostate specific antigen, and cell metasta-
sis and as inhibitors of acyl-CoA cholesterol acyl transferase. For a
review see: a) G. Veinberg, M. Vorona, I. Shestakova, I. Kanepe, E.
Lukevics, Curr. Med. Chem. 2003, 10, 1741. For selected examples,
see: b) J. W. Clader, J. Med. Chem. 2004, 47, 1; c) L. Kvaerno, T.
Ritter, M. Werder, H. Hauser, E. M. Carreira, Angew. Chem. Int.
Ed. 2004, 43, 4653; Angew. Chem. 2004, 116, 4753; d) D. A. Burnett,
Curr. Med. Chem. 2004, 11, 1873; e) M. I. Page, A. P. Laws, Tetrahe-
dron 2000, 56, 5631; f) T. M. Haley, S. J. Angier, A. D. Borthwick, R.
Singh, R. G. Micetich, Drugs 2000, 3, 512; g) P. R. Bonneau, F.
Hasani, C. Plouffe, E. Malenfant, S. R. LaPlante, I. Guse, W. W.
Ogilvie, R. Plante, W. C. Davidson, J. L. Hopkins, M. M. Morelock,
M. G. Cordingley, R. Deziel, J. Am. Chem. Soc. 1999, 121, 2965;
h) W. W. Ogilvie, C. Yoakim, F. Do, B. Hache, L. Lagace, J. Naud,
J. A. OꢁMeara, R. Deziel, Bioorg. Med. Chem. Lett. 1999, 9, 1521;
i) W. D. Vaccaro, H. R. Davis Jr., Bioorg. Med. Chem. Lett. 1998, 8,
313; j) A. D. Borthwick, G. Weingarte, T. M. Haley, M. Tomaszew-
ski, W. Wang, Z. Hu, J. Bedard, H. Jin, L. Yuen, T. S. Mansour,
Bioorg. Med. Chem. Lett. 1998, 8, 365; k) W. T. Han, A. K. Trehan,
J. J. K. Wright, M. E. Federici, S. M. Seiler, N. Meanwell, Bioorg.
Med. Chem. Lett. 1995, 3, 1123.
Tricycle (Æ)-9a: Colorless solid; m.p. 120–1228C; Rf =0.12 (hexanes/
1
ETOAc 5:1); H NMR (300 MHz, CDCl3, 258C): d=7.48 and 6.85 (d, J=
9.0 Hz, each 2H; ArH), 4.85 (t, J=2.7 Hz, 1H; =CHH), 4.79 (t, J=
1.7 Hz, 1H; =CHH), 4.72 (t, J=4.4 Hz, 1H; H2), 4.51 (d, J=5.1 Hz, 1H;
H3), 3.71 (s, 3H; MeO), 3.43 (d, J=4.1 Hz, 1H; H8), 2.54 (dt, J=15.0,
2.7 Hz, 1H; H6), 2.35 (dt, J=15.0, 1.7 Hz, 1H, H6’), 1.59 (brs, 1H; OH),
1.36 (s, 3H; Me), 1.06 ppm (s, 3H, Me); 13C NMR (75 MHz, CDCl3,
258C): d=166.1 (C9), 156.0, 151.9 (C=CH2), 120.3, 118.5 (Ar), 114.1
(Ar), 103.9 (C=CH2), 80.2 (C2), 62.2, 61.1, 59.5, 55.3 (OMe), 44.3, 42.9
(C6), 18.0 (Me), 13.1 ppm (Me); IR (CHCl3): n=3312, 1738 cmÀ1; MS
(EI): m/z (%): 300 (21) [M+H]+, 299 (100) [M]+; elemental analysis (%)
calcd for C18H21NO3 (299.4): C 72.22, H 7.07, N 4.68; found C 72.33, H
7.10, N 4.66.
Tricycle (Æ)-9b: By starting from enallenol anti-(Æ)-2k (40 mg,
0.11 mmol), followed by chromatography of the product residue (hex-
anes/EtOAc 2:1), compound (Æ)-9b (16 mg, 40%) was produced as a
1
colorless oil; Rf =0.30 (hexanes/EtOAc 2:1); H NMR (300 MHz, CDCl3,
258C): d=7.25 (m, 7H; ArH), 6.82 (d, J=9.0 Hz, 2H; ArH), 5.20 (t, J=
2.5 Hz, 1H; =CHH), 5.13 (brs, 1H; =CHH), 4.81 (t, J=5.3 Hz, 1H; H2),
4.61 (d, J=5.5 Hz, 1H; H3), 3.71 (s, 3H; OMe), 3.56 (d, J=4.5 Hz, 1H;
H8), 2.48 and 2.61 (dt, J=10.2, 1.5 Hz, each H; H6+H6’), 1.68 (brs, 1H;
OH), 1.91 ppm (s, 3H; Me); 13C NMR (75 MHz, CDCl3, 258C): d=165.1
(C9), 155.9, 149.2, 134.9 (C=CH2), 132.1, 129.1 (Ar), 128.3 (Ar), 127.0
(Ar), 118.3 (Ar), 114.0 (Ar), 109.1 (C=CH2), 80.3 (C2), 70.8, 63.2, 62.3,
55.3 (OMe), 47.1 (C7), 43.5 (C6), 20.7 ppm (Me); IR (CHCl3): n˜ =3240,
1733 cmÀ1; MS (EI): m/z (%): 362 (25) [M+H]+, 361 (100) [M]+; elemen-
tal analysis (%) calcd for C23H23NO3 (361.4): C 76.43, H 6.41, N 3.88;
found C 76.30, H 6.37, N 3.91.
[6] For reviews see: a) B. Alcaide, P. Almendros, Synlett 2002, 381; b) B.
Alcaide, P. Almendros, Chem. Soc. Rev. 2001, 30, 226; c) C. Palomo,
J. M. Aizpurua, I. Ganboa, M. Oiarbide, Synlett 2001, 1813; d) B. Al-
caide, P. Almendros, Org. Prep. Proced. Int. 2001, 33, 315; e) C.
Palomo, J. M. Aizpurua, I. Ganboa, M. Oiarbide, Amino acids, 1999,
16, 321; f) I. Ojima, F. Delaloge, Chem. Soc. Rev. 1997, 26, 377; g) I.
Ojima, Adv. Asymmetric. Synth. 1995, 1, 95; h) M. S. Manhas, D. R.
Wagle, J. Chiang, A. K. Bose, Heterocycles 1988, 27, 1755.
[7] For reviews see: a) S. Ma, Acc. Chem. Res. 2003, 36, 701; b) B. Al-
caide, P. Almendros, Eur. J. Org. Chem. 2004, 3377; c) R. W. Bates,
V. Satcharoen, Chem. Soc. Rev. 2002, 31, 12; d) A. S. K. Hashmi,
Angew. Chem. 2000, 112, 3737; Angew. Chem. Int. Ed. 2000, 39,
3590; ; e) R. Zimmer, C. U. Dinesh, E. Nandanan, F. A. Khan,
Chem. Rev. 2000, 100, 3067.
[8] a) S. Patai in The Chemistry of Ketenes, Allenes, and Related Com-
pounds, Wiley, Chichester, 1980; b) H. F. Schuster, G. M. Coppola in
Allenes in Organic Synthesis, Wiley, New York, 1984; c) P. H. Beusk-
er, J. W. Scheeren in The chemistry of dienes and polyenes, Vol. 2
(Ed.: Z. Rappoport), Wiley, 2000, pp. 331–337; d) H. Horino, M.
Kimura, S. Tanaka, T. Okajima, Y. Tamaru, Chem. Eur. J. 2003, 9,
2419 and references therein; e) M. Murakami, T. Matsuda in
Modern Allene Chemistry, Vol. 2 (Eds.: N. Krause, A. S. K. Hashmi),
Wiley-VCH, Weinheim, 2004, pp. 727–815; f) S. Ma, Chem. Rev.
2005, 105, 2829.
[9] a) B. Alcaide, P. Almendros, R. Rodríguez-Acebes, Chem. Eur. J.
2005, 11, 5708; b) B. Alcaide, P. Almendros, R. Rodríguez-Acebes, J.
Org. Chem. 2005, 70, 2713; c) B. Alcaide, P. Almendros, M. C. Re-
dondo, Org. Lett. 2004, 6, 1765; d) B. Alcaide, P. Almendros, J. M.
Alonso, M. F. Aly, Chem. Eur. J. 2003, 9, 3415; e) B. Alcaide, P. Al-
mendros, C. Aragoncillo, Chem. Eur. J. 2002, 8, 1719.
[10] For a preliminary communication of a part of this work see: B. Al-
caide, P. Almendros, C. Aragoncillo, Org. Lett. 2003, 5, 3795.
[11] a) B. Alcaide, P. Almendros, C. Aragoncillo, J. Org. Chem. 2001, 66,
1612; b) B. Alcaide, C. Pardo, C. Rodríguez-Ranera, A. Rodríguez-
Vicente, Org. Lett. 2001, 3, 4205.
Acknowledgements
Support for this work by the DGI-MCYT (Project BQU2003–07793-
C02–01) is gratefully acknowledged. C.A. and M.C.R. thank the CAM
and MEC, respectively, for predoctoral grants.
[1] “Synthesis, Stereochemistry, Synthons and Biological Evaluation”:
B. K. Banik, Curr. Med. Chem. 2004, 11, 1813.
[2] a) J. F. Fisher, S. O. Meroueh, S. Mobashery, Chem. Rev. 2005, 105,
395; b) C. Birck, J. Y. Cha, J. Cross, C. Schulze-Briese, S. O. Mer-
oueh, H. B. Schlegel, S. Mobashery, J.-P. Samama, J. Am. Chem. Soc.
2004, 126, 13945; c) C. Walsh, Antibiotics: Actions, Origins, Resist-
ance, ASM Press, Washington DC, 2003; d) O. A. Mascaretti, Bacte-
ria versus Antibacterial Agents, ASM Press, Washington, DC, 2003;
e) V. P. Sandanayaka, A. S. Prashad, Curr. Med. Chem. 2002, 9,
1145; f) C. Walsh, Nature 2000, 406, 775; g) M. I. Page, A. P. Laws,
Chem. Commun. 1998, 1609; h) D. Niccolai, L. Tarsi, R. J. Thomas,
Chem. Commun. 1997, 2333; i) V. Hook, Chem. Br. 1997, 33, 34 ;
j) B. G. Spratt, Science 1994, 264, 388; k) J. Davies, Science 1994,
264, 375; l) F. C. Neuhaus, N. H. Georgeopapadakou in Emerging
Targets in Antibacterial and Antifungal Chemoterapy (Eds.: J. Sut-
cliffe, N. H., Georgeopapadakou), Chapman and Hall, New York,
1992.
[3] They are generally referred to as trinems. For selected references
see: a) O. Kanno, I. Kawamoto, Tetrahedron 2000, 56, 5639; b) S.
Hanessian, B. Reddy, Tetrahedron 1999, 55, 3427; c) S. Biondi, A.
[12] a) B. Alcaide, Y. Martín-Cantalejo, J. Plumet, J. Rodríguez-López,
M. A. Sierra, Tetrahedron Lett. 1991, 32, 803; b) B. Alcaide, Y.
Chem. Eur. J. 2006, 12, 1539 – 1546
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1545